£45.54

American Psychiatric Association Publishing Youth Substance Abuse and Co-Occurring Disorders

4 tables, 4 figures, 20 charts

Price data last checked 12 day(s) ago - will refresh soon

View at Amazon

Price History & Forecast

Last 79 days • 79 data points (No recent data available)

Historical
Generating forecast...
£45.54 £37.57 £39.31 £41.05 £42.79 £44.53 £46.27 24 January 2026 12 February 2026 04 March 2026 23 March 2026 12 April 2026

Price Distribution

Price distribution over 79 days • 7 price levels

Days at Price
Current Price
13 days 9 days 33 days 4 days 8 days 5 days 7 days · current 0 8 17 25 33 £38 £41 £43 £43 £44 £45 £46 Days at Price

Price Analysis

Most common price: £43 (33 days, 41.8%)

Price range: £38 - £46

Price levels: 7 different prices over 79 days

Description

Youth Substance Abuse and Co-occurring Disorders provides a state-of-the art, evidence-based review of substance abuse, the prevalence of psychiatric co-morbidities, and other high-risk behaviours in youth. The contributors, renowned experts in the field of substance use disorders (SUDs), examine the theory and practice with which clinicians must be conversant to assess, treat, and develop services for adolescents with SUDs. Common co-morbid conditions include depression and schizophrenia, self-harming behaviours, and bipolar, anxiety, posttraumatic stress, attention-deficit/hyperactivity, conduct, and oppositional disorders, all of which can either precede SUD or develop as a consequence of SUD. The book's comprehensive coverage makes it an ideal text. In addition, the authors focus throughout on areas demanding further research, for example, how the respective courses of SUDs and psychiatric disorders are related, how changes occur across different types of disorders, and how trajectories of change affect the clinical course of recovery from SUD. Youth Substance Abuse and Co-occurring Disorders not only offers hands-on techniques for diagnosing and treating adolescents with SUD, it advocates for continued clinical and research investment in the dual-diagnosis domain, making it a must for clinicians, researchers, and addiction specialists.

Product Specifications

Barcode

No barcode data available